The output of Basic Pharmaceutical Products and Pharmaceutical Preparations in Finland remained relatively stable over the last decade, with slight fluctuations. From 2013 to 2016, there were gradual increases and decreases, with noticeable growth in 2016 of 20% year-on-year. However, since 2017, the output value steadied at 0.5 units and remained constant through 2023. Year-on-year growth remained flat from 2017 to 2023, with a consistent value of 0.5 units from 2018 onwards. The compound annual growth rate (CAGR) has been 0 over the last five years, indicating no growth.

Looking ahead, the forecast indicates a continuing trend of no growth up to 2028, suggesting a stagnant market environment. Future trends to monitor include:

Potential regulatory changes in the pharmaceutical sector in Finland.
Advancements in pharmaceutical technologies or discoveries that could impact production demands.
Global economic factors influencing investment in pharmaceutical manufacturing within Finland.